SAN DIEGO, March 25 /PRNewswire-FirstCall/ -- Anadys Pharmaceuticals, Inc. (Nasdaq:ANDS - News) announced today that it will present at the CanAccord Adams Hepatitis C Conference on Thursday, April 1, 2010 at 1:30 p.m. EDT (10:30 a.m. PDT). The conference is being held at the Peninsula Hotel in New York. Steve Worland, Ph.D., President and Chief Executive Officer of Anadys, will provide an overview of Anadys and its clinical development programs, ANA598 and ANA773.
